Relevance of Systematic Pre-Biologic Infectious Screening in Chronic Inflammatory Rheumatic Diseases: A Retrospective Single-Center Study
Journal of Clinical Medicine · 15.06.2026 · 15 (12) · 4631
DOI: 10.3390/jcm15124631 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.06.2026. Verfasst von Marie Doussiere und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, University Hospital of Amiens, 80000 Amiens, France. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Systematic infectious screening is recommended before initiation of biologic therapies in chronic inflammatory rheumatic diseases (CIRDs), yet the clinical impact of this strategy in low-prevalence settings remains insufficiently characterized. This study aimed to evaluate the proportion of abnormal findings and their impact on treatment management.
Methods
We conducted a retrospective single-center study including adult patients with CIRDs who underwent systematic pre-biologic infectious screening between January 2019 and June 2025. Screening included HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), interferon-γ release assay (IGRA), and chest radiography. The primary outcome was the proportion of abnormal results and their impact on biologic initiation.
Results
A total of 418 patients was included (mean age 48.2 ± 14.6 years; 69.1% female). No active HIV, HBV, or HCV infections were detected. Past HBV infection markers were identified in 2.6% of patients, and anti-HCV antibodies in 0.7%, all without detectable viremia. None of these findings required modification of biologic therapy. IGRA positivity was observed in 4.3% of patients and indeterminate results were seen in 3.1%. Preventive antituberculous therapy was initiated in most newly identified IGRA-positive cases, leading to delayed biologic initiation in several patients. Chest radiography yielded limited additional diagnostic value.
Conclusions
In this population, systematic pre-biologic infectious screening identified few clinically actionable viral infections, whereas latent tuberculosis screening represented the main determinant of therapeutic modification. These findings support continued emphasis on tuberculosis risk assessment and warrant further prospective studies to evaluate optimized and potentially targeted screening strategies incorporating cost-effectiveness analyses.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology, University Hospital of Amiens, 80000 Amiens, France.
- GRAP, INSERM U1247, Université de Picardie Jules Verne, 80000 Amiens, France.
ORCID-Profile: Marie Doussiere, Vincent Goëb
Zitieren
APA
Doussiere, M., Jouret, C., Awad, L., Bruy, P. A., Diep, L., Jesson, C., Sobhy-Danial, J. M., Grados, F., Fardellone, P., & Goëb, V. (2026). Relevance of Systematic Pre-Biologic Infectious Screening in Chronic Inflammatory Rheumatic Diseases: A Retrospective Single-Center Study. Journal of Clinical Medicine, 15(12), 4631. https://doi.org/10.3390/jcm15124631
Vancouver
Doussiere M, Jouret C, Awad L, Bruy PA, Diep L, Jesson C, et al. Relevance of Systematic Pre-Biologic Infectious Screening in Chronic Inflammatory Rheumatic Diseases: A Retrospective Single-Center Study. Journal of Clinical Medicine. 2026;15(12):4631. doi:10.3390/jcm15124631
BibTeX
@article{Doussiere2026,
author = {Doussiere, Marie and Jouret, Clémence and Awad, Lara and Bruy, Pierre-Antoine and Diep, Laetitia and Jesson, Claire and Sobhy-Danial, Jean-Marc and Grados, Franck and Fardellone, Patrice and Goëb, Vincent},
title = {Relevance of Systematic Pre-Biologic Infectious Screening in Chronic Inflammatory Rheumatic Diseases: A Retrospective Single-Center Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4631},
doi = {10.3390/jcm15124631}
}
EUVIMED